MAPK7 antibody (C-Term)
Quick Overview for MAPK7 antibody (C-Term) (ABIN220159)
Target
See all MAPK7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Detects endogenous levels of total Erk5 protein. Does not cross-react with Erk1 or Erk2. Species cross-reactivity: Human, mouse, rat and monkey.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide (KLH coupled) corresponding to carboxy-terminal residues of human Erk5.
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: IP (1:25), WB (1:1000)
Usage: Suitable for use in Western Blot and Immunoprecipitation. Western Blot: 1:1000. Immunoprecipitation: 1:25. The applications listed have been tested for the unmodified form of this product. Other forms have not been tested. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS. No stabilizing proteins added. No preservative added.
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.
-
-
- MAPK7 (Mitogen-Activated Protein Kinase 7 (MAPK7))
-
Alternative Name
- MAPK7 / ERK5
-
Background
-
Name/Gene ID: MAPK7
Subfamily: MAPK
Family: Protein Kinase
Synonyms: MAPK7, Big MAP kinase 1, BMK-1, Erk4, ERK5, MAPK 7, PRKM7, BMK1, BMK1 kinase, ERK-5, MAP kinase 7 -
Gene ID
- 5598
-
UniProt
- Q13164
-
Pathways
- MAPK Signaling, Neurotrophin Signaling Pathway, Activation of Innate immune Response, cAMP Metabolic Process, Toll-Like Receptors Cascades, Negative Regulation of intrinsic apoptotic Signaling
Target
-